Scientific Reports (Dec 2021)

Development and validation of a new scoring system for prognostic prediction of community-acquired pneumonia in older adults

  • Masahiro Shirata,
  • Isao Ito,
  • Tadashi Ishida,
  • Hiromasa Tachibana,
  • Naoya Tanabe,
  • Satoshi Konishi,
  • Issei Oi,
  • Nobuyoshi Hamao,
  • Kensuke Nishioka,
  • Hisako Matsumoto,
  • Yoshiro Yasutomo,
  • Seizo Kadowaki,
  • Hisashi Ohnishi,
  • Hiromi Tomioka,
  • Takashi Nishimura,
  • Yoshinori Hasegawa,
  • Atsushi Nakagawa,
  • Toyohiro Hirai

DOI
https://doi.org/10.1038/s41598-021-03440-3
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 10

Abstract

Read online

Abstract The discriminative power of CURB-65 for mortality in community-acquired pneumonia (CAP) is suspected to decrease with age. However, a useful prognostic prediction model for older patients with CAP has not been established. This study aimed to develop and validate a new scoring system for predicting mortality in older patients with CAP. We recruited two prospective cohorts including patients aged ≥ 65 years and hospitalized with CAP. In the derivation (n = 872) and validation cohorts (n = 1,158), the average age was 82.0 and 80.6 years and the 30-day mortality rate was 7.6% (n = 66) and 7.4% (n = 86), respectively. A new scoring system was developed based on factors associated with 30-day mortality, identified by multivariate analysis in the derivation cohort. This scoring system named CHUBA comprised five variables: confusion, hypoxemia (SpO2 ≤ 90% or PaO2 ≤ 60 mmHg), blood urea nitrogen ≥ 30 mg/dL, bedridden state, and serum albumin level ≤ 3.0 g/dL. With regard to 30-day mortality, the area under the receiver operating characteristic curve for CURB-65 and CHUBA was 0.672 (95% confidence interval, 0.607–0.732) and 0.809 (95% confidence interval, 0.751–0.856; P < 0.001), respectively. The effectiveness of CHUBA was statistically confirmed in the external validation cohort. In conclusion, a simpler novel scoring system, CHUBA, was established for predicting mortality in older patients with CAP.